EMPOWER CLINICS INC Forum: Community User: Bboy

Seh ich auch so

Sethi Laboratories ist doch eine andere Firma

Also nicht Emp?🧐

aus dem ceo.ca forum

Aber woher kommt die Info? Im Q3 sehe ich nur, dass 21Mio (0,12cad) bis zum 2. April eingelöst werden müssen.

Ceo.ca ist leider auch nicht mehr lesbar

Also so wie ich das im Forum lese macht da einer (Reality) nur Stress im Ceo.ca Forum. Er geht wohl davon aus, dass die 25M Shares am 10.03. unter die Leute gehen, findet aber selbst dort keine Zustimmung für seine Aussage. Falls jemand etwas anderes versteht oder findet, immer her damit.

Die PDF Datei ist von November 2020...

Stimmt auch wieder. Im ceo.ca Forum hab ich das gestern aber auch gelesen. Ich prüfe nochmal

Die Nachricht ist doch von 09.11.2020 oder irre ich mich da ?

🤷‍♂️ eine sehr gute Frage.

Was heißt das für uns?

""Steven McAuley, the Chief Executive Officer of the Issuer, has agreed to transfer his own free-trading shares representing 50% of the number of units issued to subscribers (other than President’s List subscribers) of the private placement in exchange for the subscribers transferring an equal portion of the restricted shares they acquire in the Offering to Mr. McAuley, and accredited investor, in accordance with applicable securities laws." https://cdn-ceo-ca.s3.amazonaws.com/1g4da1m-CSE_Form_9_-_Notice_of_Issuance_of_Securities_Nov_9_2020_FINAL.pdf

Empower Clinics KAI Medical Laboratory Annual Revenue Run Rate Now Exceeding $10,000,000 USD. Empower Anticipates Order For Next 50,000 KAI Saliva PCR Test Kits To Prepare For Demand Kai Medical Laboratory, a state-of-the-art diagnostics laboratory in Dallas, TX was acquired by Empower Clinics on October 6, 2020 to further advance the Company’s COVID-19 national testing programs, science and R&D, is now tripling in size.   VANCOUVER BC: March 8, 2021 – EMPOWER CLINICS INC. (CBDT:CSE)(EPWCF:OTCQB) (8EC:Frankfurt) (“Empower” or the “Company”) an integrated healthcare company - serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens is pleased to announce our KAI Medical Laboratory (“KAI LAB”) has achieved the following significant milestones:   Each of January and February 2021 recorded record months for specimen collection, with February delivering sequential growth of 27% over January 2021.  Exceeded a single day specimen processing of 1,000 + units in February.  As a result of record months year to date 2021, the KAI LAB annual revenue run rate is now exceeding $10,000,000 with meaningful positive cash flow.   Finally, the successful launch of our KAI Saliva PCR Test (“KAI Saliva”) generated an initial soft launch of 5,000 units, leading to the order of 25,000 additional units with a sales value of approximately $5,500,000 on January 7, 2021. Empower now anticipates placing an order for 50,000 additional KAI Saliva units with a retail sales value of approximately $11,000,000 to build inventory sufficient to meet current demand in both the United States and Canada.

https://mailchi.mp/3b7cc2511113/air-travellers-entering-canada-must-have-a-negative-covid-19-test-before-arrival-13384618?e=e2b9b985b4

Ui heute mal tiefgrün 🤔🤔🤔